PDCD1 and lung carcinoma: In vitro, mouse lung cancer cell line M109 viability was improved by PD-1 knockout or antibody blockage, and in immune-deficient animals, M109-xenograft tumors developed more quickly as a result of PD-1 suppression, exhibiting enhanced proliferation and reduced apoptosis [199].